CardioSolv Overview
- Year Founded
-
2009

- Status
-
Out of Business
- Employees
-
5

- Latest Deal Type
-
Out of Business
CardioSolv General Information
Description
Operator of a private scientific services and consulting company intended to treat patients suffering from arrhythmia. The company helps to improve outcomes for patients who undergo ventricular tachycardia ablation procedures and also reduces the procedure time and cost, enabling healthcare practitioners to improve the lives of their patients.
Contact Information
Website
www.cardiosolv.comCorporate Office
- 2443 Maryland Avenue
- Baltimore, MD 21218
- United States
Corporate Office
- 2443 Maryland Avenue
- Baltimore, MD 21218
- United States
CardioSolv Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Out of Business | 20-Dec-2023 | Completed | Out of Business | |||
5. Grant | 01-Jun-2019 | Completed | Generating Revenue | |||
4. Seed Round | 24-Feb-2017 | Completed | Generating Revenue | |||
3. Accelerator/Incubator | 27-Aug-2014 | Completed | Generating Revenue | |||
2. Grant | 01-Aug-2014 | $1.33M | $250K | Completed | Generating Revenue | |
1. Seed Round | 27-Jun-2012 | $250K | $250K | Completed | Generating Revenue |
CardioSolv Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed |
CardioSolv Patents
CardioSolv Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11532078-B2 | Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuit | Active | 03-Dec-2015 | ||
US-20200273170-A1 | Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuit | Active | 03-Dec-2015 | ||
US-20190378272-A1 | Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuit | Active | 03-Dec-2015 | ||
US-10679348-B2 | Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuit | Inactive | 03-Dec-2015 | ||
US-20170161896-A1 | Systems and methods for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuits | Active | 03-Dec-2015 | G06T7/0012 |
CardioSolv Signals
CardioSolv FAQs
-
When was CardioSolv founded?
CardioSolv was founded in 2009.
-
Where is CardioSolv headquartered?
CardioSolv is headquartered in Baltimore, MD.
-
What is the size of CardioSolv?
CardioSolv has 5 total employees.
-
What industry is CardioSolv in?
CardioSolv’s primary industry is Other Healthcare Technology Systems.
-
Is CardioSolv a private or public company?
CardioSolv is a Private company.
-
What is CardioSolv’s current revenue?
The current revenue for CardioSolv is
. -
How much funding has CardioSolv raised over time?
CardioSolv has raised $302K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »